Advanced search
Publication Cover
HIV Clinical Trials Volume 2, 2001 - Issue 6
Submit an article Journal homepage
80
Views
45
CrossRef citations to date
0
Altmetric
Original Articles

Pharmacokinetics of Saquinavir-SGC in HIV-Infected Pregnant Women

Edward P. AcostaUniversity of Alabama at Birmingham, Birmingham, Alabama, USA.Correspondence[email protected].
,
Carmen ZorrillaUniversity of Puerto Rico, San Juan, Puerto Rico
,
Russell Van DykeTulane University Medical SchoolNew Orleans, Louisiana
,
Arlene BardeguezUniversity of Medicine and Dentistry of New Jersey, Newark, USA
,
Elizabeth SmithDivision of AIDSNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
,
Michael HughesHarvard School of Public HealthBoston, Massachusetts
,
Sharon HuangHarvard School of Public HealthBoston, Massachusetts
,
Jane PittColumbia University College, New York, USA
,
Heather WattsNational Institute of Child Health and Human DevelopmentRockville, Maryland, USA
,
Lynne MofensonNational Institute of Child Health and Human DevelopmentRockville, Maryland, USA
& Pediatric AIDS Clinical Trials Group 386 Protocol Team show all
Pages 460-465 | Published online: 02 Feb 2015

REFERENCES

  • Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet. 1997;33:328–343.
  • Acosta EP, Kakuda TN, Brundage RC, Anderson PL, Fletcher CV. Pharmacodynamics of HIV-1 protease inhibi-tors. Clin Infect Dis. 2000;30(S4S151–S159.
  • Lalezari J. Selecting the optimum dose for a new soft gelatin capsule formulation of saquinavir. J Acquir Immune Defic Syn Human Retrovirol. 1998;19:195–196.
  • Ha HR, Follath F, Bloemhard Y, Krahenbuhl S. Determina-tion of saquinavir in human plasma by high-performance liquid chromatography. J Chromatogr B. 1997;694:427–433.
  • Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York, NY: Marcel Dekker; 1982.
  • Fortovase (saquinavir) [prescribing information]. Nutley, NJ: Roche Laboratories, Inc.; 1997.
  • Cox S, Conway B, Freimuth W, et al. Pilot study of BID and TID combinations of saquinavir-SGC (5), Delavirdine (D), zidovudine (ZDV) and lamivudine (3TC) as initial therapy: Pharmacokinetic interaction between S-SGC and D. Sev-enth Conference on Retroviruses and Opportunistic Infec-tions; January 30-February 2, 2000; San Francisco, Cali-fornia. Abstract 82.
  • Vithayasai V, Hawkins D, Subjatura V, et al. Safety and efficacy of saquinavir-soft gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical transmission. Seventh European Conference on Clinical Aspects and Treatment of HIV Infection; October 23–27, 1999; Lisbon, Portugal. Abstract LB1215.
  • Gieschke R, Fotteler B, Buss N, Steimer J-L. Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patients. Clin Pharmacokinet. 1999;37:75–86.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.